{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:23:13Z","timestamp":1761567793713,"version":"build-2065373602"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cpet.2021.03.009","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T19:07:45Z","timestamp":1622142465000},"page":"429-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders"],"prefix":"10.1016","volume":"16","author":[{"given":"Majid","family":"Assadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Jokar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Yordanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Gholamrezanezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullatif","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Biersack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Nabipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojjat","family":"Ahmadzadehfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpet.2021.03.009_bib1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jama.1946.02870490016004","article-title":"Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid","volume":"132","author":"Seidlin","year":"1946","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.cpet.2021.03.009_bib2","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","article-title":"EANM procedure guidelines for therapy of benign thyroid disease","volume":"37","author":"Stokkel","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1091","key":"10.1016\/j.cpet.2021.03.009_bib3","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170969","article-title":"Theranostic radiopharmaceuticals: established agents in current use","volume":"91","author":"Ballinger","year":"2018","journal-title":"Br J Radiol."},{"key":"10.1016\/j.cpet.2021.03.009_bib4","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.2147\/OTT.S140671","article-title":"Theranostics in nuclear medicine practice","volume":"10","author":"Yordanova","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.cpet.2021.03.009_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1517\/17425247.2.6.1075","article-title":"Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases","volume":"2","author":"Dadachova","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"issue":"1 Suppl 1","key":"10.1016\/j.cpet.2021.03.009_bib6","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1053\/j.seminoncol.2005.01.010","article-title":"Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets","volume":"32","author":"Maloney","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cpet.2021.03.009_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/157016310793360684","article-title":"Current concepts and future directions in radioimmunotherapy","volume":"7","author":"I Lin","year":"2010","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.cpet.2021.03.009_bib8","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/BF00800606","article-title":"The contribution of nuclear medicine to the patient with infection","volume":"22","author":"Becker","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib9","first-page":"193","article-title":"Treatment of infection with radiolabeled antibodies","volume":"50","author":"Dadachova","year":"2006","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2021.03.009_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0883-2897(91)90005-6","article-title":"Imaging of systemic Candida albicans infections with a radioiodinated monoclonal antibody: experimental study in the Guinea pig","volume":"18","author":"Poulain","year":"1991","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.cpet.2021.03.009_bib11","first-page":"651","article-title":"Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody","volume":"29","author":"Rubin","year":"1988","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00006231-198703000-00003","article-title":"In\u00a0vivo tuberculoma creation and its radioimmunoimaging","volume":"8","author":"Hazra","year":"1987","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.cpet.2021.03.009_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0883-2897(92)90184-Z","article-title":"Radioimmunoscintigraphic approach for the in\u00a0vivo detection of tuberculomas\u2014a preliminary study in a rabbit model","volume":"19","author":"Malpani","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.cpet.2021.03.009_bib14","first-page":"783","article-title":"Detection of bacterial endocarditis with technetium-99m-labeled antistaphylococcal antibody","volume":"21","author":"Huang","year":"1980","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib15","first-page":"1028","article-title":"Immunoscintigraphy of Pneumocystis carinii pneumonia in AIDS patients","volume":"35","author":"Goldenberg","year":"1994","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.semnuclmed.2008.10.007","article-title":"Radioimmunotherapy of infectious diseases","volume":"39","author":"Dadachova","year":"2009","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib17","doi-asserted-by":"crossref","first-page":"10942","DOI":"10.1073\/pnas.1731272100","article-title":"Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection","volume":"100","author":"Dadachova","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cpet.2021.03.009_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cpet.2021.03.009_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/AAC.00473-11","article-title":"Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice","volume":"56","author":"Jiang","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cpet.2021.03.009_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/654813","article-title":"Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection","volume":"202","author":"Bryan","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cpet.2021.03.009_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2217\/fmb.13.79","article-title":"Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells","volume":"8","author":"Bryan","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib22","doi-asserted-by":"crossref","first-page":"5629s","DOI":"10.1158\/1078-0432.CCR-07-0870","article-title":"Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F (ab\u2032) 2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection","volume":"13","author":"Dadachova","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cpet.2021.03.009_bib23","first-page":"313","article-title":"Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to \u03b3-radiation versus radioimmunotherapy with \u03b1-and \u03b2-emitting radioisotopes","volume":"45","author":"Dadachova","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1286-4579(99)80084-7","article-title":"Molecular epidemiology, pathogenesis, and genetics of the dimorphic fungus Histoplasma capsulatum","volume":"1","author":"Retallack","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.cpet.2021.03.009_bib25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI19361","article-title":"Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum","volume":"112","author":"Nosanchuk","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cpet.2021.03.009_bib26","first-page":"330","article-title":"Radioimmunotherapy as a novel approach in HIV, bacterial, and fungal infectious diseases","volume":"33","author":"Helal","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.cpet.2021.03.009_bib27","doi-asserted-by":"crossref","first-page":"G38","DOI":"10.1016\/j.vaccine.2009.09.105","article-title":"Monoclonal antibody-based therapies for microbial diseases","volume":"27","author":"Saylor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cpet.2021.03.009_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.11.1.1","article-title":"Use of licensed vaccines for active immunization of the immunocompromised host","volume":"11","author":"Pirofski","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cpet.2021.03.009_bib29","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.38.8.1695","article-title":"Serum therapy revisited: animal models of infection and development of passive antibody therapy","volume":"38","author":"Casadevall","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cpet.2021.03.009_bib30","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/AAC.48.5.1624-1629.2004","article-title":"Feasibility of radioimmunotherapy of experimental pneumococcal infection","volume":"48","author":"Dadachova","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cpet.2021.03.009_bib31","doi-asserted-by":"crossref","first-page":"290750","DOI":"10.1155\/2013\/290750","article-title":"Rhenium-188 production in hospitals, by W-188\/Re-188 generator, for easy use in radionuclide therapy","volume":"2013","author":"Argyrou","year":"2013","journal-title":"Int J Mol Imaging"},{"key":"10.1016\/j.cpet.2021.03.009_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fmed.2019.00132","article-title":"Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives","volume":"6","author":"Lepareur","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib33","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1128\/AAC.01269-08","article-title":"Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax","volume":"53","author":"Rivera","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cpet.2021.03.009_bib34","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00330-002-1612-y","article-title":"Imaging of pulmonary tuberculosis","volume":"13","author":"Van Dyck","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.nucmedbio.2014.08.005","article-title":"Nuclear imaging: a powerful novel approach for tuberculosis","volume":"41","author":"Johnson","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.cpet.2021.03.009_bib36","first-page":"214","article-title":"The menace of tuberculosis and the role of nuclear medicine in tackling it. Now its time to tighten the loose strings","volume":"12","author":"Gupta","year":"2009","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0026-0495(96)90092-X","article-title":"Somatostatin receptor expression in clinical immunology","volume":"45","author":"Van Hagen","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.cpet.2021.03.009_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00173035","article-title":"Somatostatin analogue scintigraphy in granulomatous diseases","volume":"21","author":"Vanhagen","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV","volume":"347","author":"Little","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/1874471010801030234","article-title":"Radioimmunotherapy of infection with 213Bi-labeled antibodies","volume":"1","author":"Dadachova","year":"2008","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.cpet.2021.03.009_bib41","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1371\/journal.pmed.0030427","article-title":"Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins","volume":"3","author":"Dadachova","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib42","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM198912143212401","article-title":"Quantitation of human immunodeficiency virus type 1 in the blood of infected persons","volume":"321","author":"Ho","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib43","first-page":"19","article-title":"Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists","volume":"12","author":"De","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.cpet.2021.03.009_bib44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cpet.2021.03.009_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cpet.2021.03.009_bib46","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2174\/1568026614666140827143541","article-title":"Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis","volume":"14","author":"Choi","year":"2014","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.cpet.2021.03.009_bib47","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","article-title":"The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours","volume":"40","author":"Zaknun","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.cpet.2021.03.009_bib48","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1530\/ERC-19-0186","article-title":"The next generation of peptide receptor radionuclide therapy","volume":"26","author":"Brabander","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.cpet.2021.03.009_bib49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/eurheartj\/ehn070","article-title":"Ultrasound imaging techniques for the evaluation of cardiovascular therapies","volume":"29","author":"Kastelein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpet.2021.03.009_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13139-016-0418-9","article-title":"Recent advances in the development of PET\/SPECT probes for atherosclerosis imaging","volume":"50","author":"Shimizu","year":"2016","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2021.03.009_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2008.03.036","article-title":"Radionuclide imaging: a molecular key to the atherosclerotic plaque","volume":"52","author":"Langer","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12410-019-9491-7","article-title":"Radionuclide imaging of atherothrombotic diseases","volume":"12","author":"Stacy","year":"2019","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1016\/j.cpet.2021.03.009_bib53","first-page":"187","article-title":"Translational molecular nuclear cardiology","volume":"34","author":"Thackeray","year":"2016","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cpet.2021.03.009_bib54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A\u00a0dual tracer 68 Ga-DOTANOC PET\/CT and 18 F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.cpet.2021.03.009_bib55","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s12350-016-0766-y","article-title":"Molecular imaging of atherosclerosis with integrated PET imaging","volume":"24","author":"Hammad","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib56","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1152\/ajpendo.00048.2003","article-title":"Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells","volume":"285","author":"Dalm","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cpet.2021.03.009_bib57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.semnuclmed.2018.02.005","article-title":"Nuclear imaging in sarcoidosis","volume":"48","author":"Piekarski","year":"2018","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib58","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccm.2008.03.012","article-title":"Treatment of sarcoidosis","volume":"29","author":"Baughman","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12350-018-01488-9","article-title":"Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis","volume":"26","author":"Bravo","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib60","first-page":"21","article-title":"Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis","volume":"42","author":"Lebtahi","year":"2001","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12149-016-1095-6","article-title":"The utility of PET\/CT with 68 Ga-DOTATOC in sarcoidosis: comparison with 67 Ga-scintigraphy","volume":"30","author":"Nobashi","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","article-title":"Imaging of myocardial inflammation with somatostatin receptor based PET\/CT\u2014a comparison to cardiac MRI","volume":"194","author":"Lapa","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib63","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F] FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib64","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.jacc.2013.08.1624","article-title":"Peptide receptor\u2013targeted radionuclide therapy alters inflammation in atherosclerotic plaques","volume":"62","author":"Schatka","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cpet.2021.03.009_bib65","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cpet.2021.03.009_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2012.06476.x","article-title":"Evolving role of molecular imaging for new understanding: targeting myofibroblasts to predict remodeling","volume":"1254","author":"de Haas","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cpet.2021.03.009_bib67","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A\u00a0tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41181-019-0069-0","article-title":"Targeting of activated fibroblasts for imaging and therapy","volume":"4","author":"Lindner","year":"2019","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.cpet.2021.03.009_bib69","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","article-title":"Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04","volume":"60","author":"Varasteh","year":"2019","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib70","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib71","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.7150\/thno.19119","article-title":"[177Lu] pentixather: comprehensive preclinical characterization of a first CXCR4-directed endoradiotherapeutic agent","volume":"7","author":"Schottelius","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.cpet.2021.03.009_bib72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.cpet.2021.03.009_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11886-018-0955-1","article-title":"PET assessment of immune cell activity and therapeutic monitoring following myocardial infarction","volume":"20","author":"Thackeray","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cpet.2021.03.009_bib74","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jcmg.2015.09.007","article-title":"[68Ga] Pentixafor-PET\/CT for imaging of chemokine receptor 4 expression after myocardial infarction","volume":"8","author":"Lapa","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpet.2021.03.009_bib75","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","article-title":"Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction","volume":"8","author":"Thackeray","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpet.2021.03.009_bib76","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.117.196485","article-title":"Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using 68Ga-pentixafor PET: correlation with cardiovascular risk factors and calcified plaque burden","volume":"59","author":"Weiberg","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib77","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cpet.2021.03.009_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1759720X13511197","article-title":"Sarcoidois: is it only a mimicker of primary rheumatic disease? A single center experience","volume":"6","author":"Kobak","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.cpet.2021.03.009_bib79","article-title":"Co-occurrence of rheumatoid arthritis and sarcoidosis","volume":"2015","author":"Kobak","year":"2015","journal-title":"Case Rep"},{"key":"10.1016\/j.cpet.2021.03.009_bib80","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0021-9258(19)85035-4","article-title":"Distinct subsets of somatostatin receptors on cultured human lymphocytes","volume":"264","author":"Sreedharan","year":"1989","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cpet.2021.03.009_bib81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2362.1991.tb01803.x","article-title":"Production of neuropeptides by inflammatory cells within the granulomas of murine schistosomiasis mansoni","volume":"21","author":"Weinstock","year":"1991","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cpet.2021.03.009_bib82","first-page":"233","article-title":"Somatostatin treatment for pain in rheumatoid arthritis: a double blind versus placebo study in knee involvement","volume":"16","author":"Matucci-Cerinic","year":"1998","journal-title":"Med Sci Res"},{"key":"10.1016\/j.cpet.2021.03.009_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-016-0202-y","article-title":"Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sj\u00f6gren\u2019s syndrome treated with Infliximab: a pilot study","volume":"6","author":"Anzola-Fuentes","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.cpet.2021.03.009_bib84","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.1780371017","article-title":"Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis","volume":"37","author":"Vanhagen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpet.2021.03.009_bib85","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1189\/jlb.0606417","article-title":"Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages","volume":"81","author":"Armani","year":"2007","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.cpet.2021.03.009_bib86","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s002590050297","article-title":"Somatostatin receptor imaging in patients with sarcoidosis","volume":"25","author":"Kwekkeboom","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib87","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1164\/rccm.201603-0579LE","article-title":"Peptide receptor radionuclide therapy for sarcoidosis","volume":"194","author":"Lapa","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpet.2021.03.009_bib88","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.1999.00498.x","article-title":"Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas","volume":"29","author":"Bokum","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cpet.2021.03.009_bib89","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7150\/thno.22161","article-title":"Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis-initial experience in two patients","volume":"8","author":"Lapa","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.cpet.2021.03.009_bib90","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/ard.61.6.573","article-title":"Long acting somatostatin analogue for the treatment of refractory RA","volume":"61","author":"Koseoglu","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpet.2021.03.009_bib91","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0003-4967(24)43390-6","article-title":"A\u00a0pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis","volume":"60","author":"Paran","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpet.2021.03.009_bib92","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/ATVBAHA.108.165498","article-title":"Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation","volume":"29","author":"Choudhury","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpet.2021.03.009_bib93","doi-asserted-by":"crossref","first-page":"W477","DOI":"10.2214\/AJR.11.8275","article-title":"Adaptive iterative dose reduction using 3D processing for reduced-and low-dose pulmonary CT: comparison with standard-dose CT for image noise reduction and radiological findings","volume":"199","author":"Ohno","year":"2012","journal-title":"Am J Roentgenol"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859821000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859821000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:09:14Z","timestamp":1761563354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859821000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1556859821000237"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2021.03.009","relation":{},"ISSN":["1556-8598"],"issn-type":[{"type":"print","value":"1556-8598"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2021.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}